| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $353K | -96.6% |
| R&D Expense | $42.3M | -1.2% |
| SG&A Expense | $13.0M | -7.2% |
| Operating Income | -$54.9M | -18.3% |
| Pre-tax Income | -$50.4M | -11.1% |
| Income Tax | $0 | — |
| Net Income | -$50.4M | -11.1% |
| EPS (Basic) | -$0.94 | +41.3% |
| EPS (Diluted) | -$0.94 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.5M | +125.9% |
| Current Assets | $103.0M | +27.4% |
| Total Assets | $120.7M | +26.0% |
| Current Liabilities | $16.4M | +18.4% |
| Stockholders' Equity | $90.7M | +26.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.2M | +20.7% |
| Capital Expenditures | $4.2M | +156.9% |
| Investing Cash Flow | -$20.1M | -142.6% |
| Financing Cash Flow | $66.2M | +1115.0% |
| Free Cash Flow | -$37.4M | +14.0% |
| +41.3% |